Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17825 | 580 | 33.8 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
1157 | 2 | FIBRINOLYSIS//PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1 | 9477 |
17825 | 1 | INTERNAL MED THER EUTCLIN MED//24 H PLATELET ACTIVITY//AB INITIO SCF DFT | 580 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INTERNAL MED THER EUTCLIN MED | address | 70193 | 0% | 67% | 2 |
2 | 24 H PLATELET ACTIVITY | authKW | 52646 | 0% | 100% | 1 |
3 | AB INITIO SCF DFT | authKW | 52646 | 0% | 100% | 1 |
4 | ADDITIONAL THERAPEUTIC EFFECTS | authKW | 52646 | 0% | 100% | 1 |
5 | ANGIOTENSIN II TYPE I RECEPTOR MESSENGER RNA | authKW | 52646 | 0% | 100% | 1 |
6 | ANGIOTENSIN THROMBOXANE RECEPTOR ANTAGONISM | authKW | 52646 | 0% | 100% | 1 |
7 | ANIMAL THROMBOSIS MODEL | authKW | 52646 | 0% | 100% | 1 |
8 | ANITHROMBOTIC AGENTS | authKW | 52646 | 0% | 100% | 1 |
9 | ANTI AGGREGATORY EFFECT | authKW | 52646 | 0% | 100% | 1 |
10 | ANTIPLATETLET | authKW | 52646 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 7101 | 33% | 0% | 189 |
2 | Cardiac & Cardiovascular System | 1738 | 22% | 0% | 129 |
3 | Hematology | 1364 | 15% | 0% | 89 |
4 | Pharmacology & Pharmacy | 1086 | 27% | 0% | 155 |
5 | Medicine, General & Internal | 85 | 7% | 0% | 42 |
6 | Medicine, Research & Experimental | 73 | 5% | 0% | 31 |
7 | Physiology | 21 | 3% | 0% | 18 |
8 | Endocrinology & Metabolism | 15 | 3% | 0% | 19 |
9 | Urology & Nephrology | 14 | 2% | 0% | 13 |
10 | Chemistry, Medicinal | 5 | 2% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNAL MED THER EUTCLIN MED | 70193 | 0% | 67% | 2 |
2 | CARDIOVASC PREVENT CARDIOVASC DIS | 52646 | 0% | 100% | 1 |
3 | CLIN MED 1IRCCS | 52646 | 0% | 100% | 1 |
4 | CLINI PHARM PHARMACOTHE | 52646 | 0% | 100% | 1 |
5 | EXCELLENCE AGING DRUG SCI | 52646 | 0% | 100% | 1 |
6 | HAEMOSTASIS THROMOBIS VASC BIOL UNIT | 52646 | 0% | 100% | 1 |
7 | IRCC POLICLIN S MATTEO | 52646 | 0% | 100% | 1 |
8 | J PAUL STICHL AGING | 52646 | 0% | 100% | 1 |
9 | MED CLIN 2FDN IRCC POLICLIN S MATTEO | 52646 | 0% | 100% | 1 |
10 | MED MED JULES THORN | 52646 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THROMBOSIS RESEARCH | 5572 | 6% | 0% | 33 |
2 | JOURNAL OF HUMAN HYPERTENSION | 4636 | 3% | 0% | 18 |
3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 3723 | 5% | 0% | 28 |
4 | JOURNAL OF HYPERTENSION | 3655 | 4% | 0% | 26 |
5 | THROMBOSIS AND HAEMOSTASIS | 3014 | 4% | 0% | 24 |
6 | AMERICAN JOURNAL OF HYPERTENSION | 2263 | 3% | 0% | 16 |
7 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1884 | 3% | 0% | 16 |
8 | GIORNALE DI GERONTOLOGIA | 1878 | 0% | 4% | 1 |
9 | KARDIOLOGIYA | 1559 | 2% | 0% | 14 |
10 | PROSTAGLANDINS LEUKOTRIENES AND MEDICINE | 1494 | 1% | 1% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FOGARI, R , ZOPPI, A , SALVADEO, SAT , MUGELLINI, A , LAZZARI, P , SANTORO, T , DEROSA, G , (2011) FIBRINOLYSIS AND INSULIN SENSITIVITY IN IMIDAPRIL AND CANDESARTAN (FISIC STUDY) RECIPIENTS WITH HYPERTENSION.HYPERTENSION RESEARCH. VOL. 34. ISSUE 4. P. 509-515 | 28 | 54% | 6 |
2 | FOGARI, R , ZOPPI, A , MUGELLINI, A , MAFFIOLI, P , LAZZARI, P , DEROSA, G , (2011) ROLE OF ANGIOTENSIN II IN PLASMA PAI-1 CHANGES INDUCED BY IMIDAPRIL OR CANDESARTAN IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME.HYPERTENSION RESEARCH. VOL. 34. ISSUE 12. P. 1321-1326 | 25 | 60% | 8 |
3 | KAMINSKA, M , MUSIAL, WJ , CHABIELSKA, E , (2013) ANGIOTENSIN II: THE RISK FACTOR FOR ARTERIAL THROMBOSIS.KARDIOLOGIA POLSKA. VOL. 71. ISSUE 4. P. 410-416 | 25 | 52% | 0 |
4 | BLANN, AD , NADAR, S , LIP, GYH , (2003) PHARMACOLOGICAL MODULATION OF PLATELET FUNCTION IN HYPERTENSION.HYPERTENSION. VOL. 42. ISSUE 1. P. 1-7 | 34 | 38% | 46 |
5 | FOGARI, R , ZOPPI, A , (2006) ANTIHYPERTENSIVE DRUGS AND FIBRINOLYTIC FUNCTION - IMPACT OF DUAL CALCIUM CHANNEL AND RENIN-ANGIOTENSIN SYSTEM BLOCKADE.AMERICAN JOURNAL OF HYPERTENSION. VOL. 19. ISSUE 12. P. 1293-1299 | 27 | 44% | 29 |
6 | REMKOVA, A , REMKO, M , (2010) THE ROLE OF RENIN-ANGIOTENSIN SYSTEM IN PROTHROMBOTIC STATE IN ESSENTIAL HYPERTENSION.PHYSIOLOGICAL RESEARCH. VOL. 59. ISSUE 1. P. 13-23 | 23 | 43% | 27 |
7 | LOTTERMOSER, K , HERTFELDER, HJ , VETTER, H , DUSING, R , (2000) RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND FIBRINOLYSIS.MEDIZINISCHE KLINIK. VOL. 95. ISSUE 12. P. 683 -688 | 30 | 43% | 2 |
8 | SCHWIELER, JH , KAHAN, T , WALLEN, NH , NUSSBERGER, J , HJEMDAHL, P , (2013) INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM DOES NOT REDUCE PLATELET ACTIVITY AT REST OR DURING STRESS IN HYPERTENSION.JOURNAL OF HYPERTENSION. VOL. 31. ISSUE 8. P. 1676-1682 | 18 | 49% | 5 |
9 | FOGARI, R , ZOPPI, A , MUGELLINI, A , LAZZARI, P , DEROSA, G , (2010) DIFFERENT EFFECTS OF ALISKIREN AND LOSARTAN ON FIBRINOLYSIS AND INSULIN SENSITIVITY IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME.HORMONE AND METABOLIC RESEARCH. VOL. 42. ISSUE 12. P. 892 -896 | 16 | 55% | 13 |
10 | HJEMDAHL, P , WALLEN, NH , (1997) CALCIUM ANTAGONIST TREATMENT, SYMPATHETIC ACTIVITY AND PLATELET FUNCTION.EUROPEAN HEART JOURNAL. VOL. 18. ISSUE . P. A36 -A50 | 34 | 37% | 35 |
Classes with closest relation at Level 1 |